Literature DB >> 8684125

Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas.

D P Kelsell, N K Spurr, D M Barnes, B Gusterson, D T Bishop.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8684125     DOI： 10.1016/s0140-6736(96)90707-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site.

Authors:  H Ruffner; W Jiang; A G Craig; T Hunter; I M Verma
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  Prognostic significance of the allelic loss of the BRCA1 gene in colorectal cancer.

Authors:  J M Garcia; R Rodriguez; G Dominguez; J M Silva; M Provencio; J Silva; A Colmenarejo; I Millan; C Muñoz; C Salas; S Coca; P España; F Bonilla
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

3.  Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma.

Authors:  I Bièche; C Noguès; S Rivoilan; A Khodja; A Latil; R Lidereau
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa.

Authors:  S Staff; J J Isola; O Johannsson; A Borg; M M Tanner
Journal:  Br J Cancer       Date:  2001-10-19       Impact factor: 7.640

5.  Family history and survival in premenopausal breast cancer.

Authors:  S N Mohammed; P Smith; S V Hodgson; I S Fentiman; D W Miles; D M Barnes; R R Millis; R D Rubens
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.